United States v. WARREN

CourtDistrict Court, E.D. Pennsylvania
DecidedJuly 13, 2022
Docket2:21-cv-04511
StatusUnknown

This text of United States v. WARREN (United States v. WARREN) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. WARREN, (E.D. Pa. 2022).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA

UNITED STATES OF AMERICA, : : CIVIL ACTION Plaintiff, : : v. : : NO. 21-4511 TIMOTHY D. WARREN, and TITAN : MEDICAL COMPLIANCE, LLC, : : Defendants. :

MEMORANDUM

Goldberg, J. July 13, 2022

In this unnecessarily protracted case, Plaintiff the United States of America (“Plaintiff” or the “Government”) has brought claims under the False Claims Act against Defendants Timothy D. Warren and his wholly-owned company Titan Medical Compliance, LLC (“Titan Medical”) (collectively, “Defendants”). Defendants have moved to transfer venue, pursuant to Federal Rule of Civil Procedure 28 U.S.C. § 1404(a), to the United States District Court for the District of Kansas. For the following reasons, I will deny Defendants’ Motion to Transfer. I. FACTUAL AND PROCEDURAL BACKGROUND A. Allegations in the Complaint The claims at issue arise out of events between the years of 2014 and 2018 when Defendants allegedly falsely promoted auricular electro-acupuncture devices, specifically the P-Stim, ANSiStim, and Stivax devices, as reimbursable by Medicare, and other federal insurers, and as approved by the Food and Drug Administration (“FDA”). According to the Complaint, even though such devices were not approved by the FDA or reimbursable by Medicare, Defendants were paid thousands of dollars to convince medical providers that they could reap profits by billing federal insurers for these devices. (Compl. pp. 1–2.) According to the Complaint, this scheme was carried out across the United States. The Complaint gives three specific examples of Defendants’ interactions with medical providers that resulted in false claims: one in Pennsylvania, one in Texas, and one in Tennessee. (Id. ¶¶ 146–222.) With respect to the Pennsylvania claims, the Complaint alleges that Defendants gave coding advice about the Stivax device to Sagi Kuznits, M.D., a board-certified neurosurgeon with multiple locations in Pennsylvania, causing Dr. Kuznits to submit over fifty false claims to Medicare, for which Medicare paid nearly $400,000. (Id. ¶¶ 147–59.) B. Procedural History On October 14, 2021, Plaintiff, the United States of America, filed a Complaint against Defendants, alleging violations of the False Claims Act. By stipulation of the parties, Defendants were

given an extension until December 14, 2021 to file a responsive pleading, and then a second extension until January 14, 2022. On December 30, 2021, defense counsel, Brem Moldovsky, submitted a letter requesting leave to withdraw based on Defendants’ failure to either communicate with him or pay the contractual fees owed to counsel’s firm. I held a status conference with the parties and counsel to address defense counsel’s letter. At that time, Plaintiff indicated that the parties had engaged in significant settlement discussions and that Plaintiff was awaiting certain documentation from Defendants in order to finalize the settlement. Defense counsel confirmed that such discussions had occurred and that he had been attempting to obtain the required documentation from Defendants. Defendant Dr. Timothy Warren explained that he had suffered some recent personal tragedy and needed some additional time to comply with Plaintiff’s requests. Based on the representations at the conference, I issued an order denying defense counsel leave to withdraw and granting Defendants thirty days—until the end of February 2022—in which to file an answer to the Complaint. I also directed that, if the case did not settle prior to the answer deadline, defense counsel could renew the request to withdraw. During a follow-up status conference on March 1, 2022, Defendants discussed their intent to file a motion to dismiss but noted that they were still interested in settling the matter without further litigation. Plaintiff’s counsel responded that before the case could be resolved, the Government still needed previously-requested documentation from Defendants in order to perform an ability-to-pay analysis. Based on assurances from Defendants that they would promptly turn over these documents, I issued an order which again stayed the deadline for Defendants to file a responsive pleading. During the thirty-day stay, I directed Defendants to immediately produce all documents requested by Plaintiff for the ability-to-pay analysis. Notwithstanding this Order, Plaintiff reported, by way of a March 31, 2022 letter, that it had not received a substantial number of documents requested and, as such, could not complete its ability-to-

pay analysis. Defendants responsive letter conceded they had not yet turned over all of the documents but had turned over at least some of the requested information. Defendants’ letter further indicated that Dr. Warren’s personal tragedy in January 2022 had inhibited his ability to gather the required information. Based on the parties’ letters, and not wishing to delay the matter any further, I issued a March 31, 2022 Order giving Defendants five business days in which to file either an answer to the complaint or a motion pursuant to Federal Rule of Civil Procedure 12(b)(6). On April 6, 2022, Defendants filed a lengthy motion to dismiss for lack of personal jurisdiction, improper venue, failure to join necessary parties, and failure to state a claim, or, in the alternative, to transfer venue for forum non conveniens. Shortly thereafter, on May 4, 2022, the parties submitted a joint stipulation noting that the parties had continued to confer in good faith and agreed to the following: 1. The United States agrees to voluntarily dismiss Count III (Payment by Mistake of its Complaint [Dkt. No. 1]; 2. Defendants agree to withdraw the Motion [to Dismiss]; 3. The Parties agree to preserve Defendants’ ability to raise arguments under 28 U.S.C. § 1404(a) to transfer the case to the District of Kansas up to the final pretrial conference (although the United States does not concede the merits of any such arguments and reserves all of its defenses to and arguments against any transfer motion); and 4. Defendants shall answer the Complaint within 60 days of this stipulation.

(ECF No. 25.) Defense counsel submitted another letter, dated May 26, 2022, seeking leave to withdraw based on Defendants’ complete lack of cooperation or communication with counsel, as well as Defendants’ refusal to pay counsel for services rendered. On June 6, 2022, I issued an Order denying defense counsel’s request for leave to withdraw and directing that Defendants file an answer to the Complaint by July 6, 2022, with no further extensions to be granted. The Order further stated that: Defendants are put on notice that defense counsel retains an obligation under Federal Rule of Civil Procedure 11(b) to only file pleadings that are factually and legally substantiated. As such defense counsel cannot file an answer without Defendants’ full and complete cooperation and willingness to provide the required information. If defense counsel cannot file an answer due to Defendants’ lack of communication, lack of candor, or refusal to fully participate, counsel shall so notify the Court. Defendants are advised that default may be entered against them and in favor of the Government if an answer is not filed due to Defendants’ lack of cooperation.

(ECF No. 26.) On June 14, 2022, Defendants renewed their motion to transfer venue to the District of Kansas.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Van Dusen v. Barrack
376 U.S. 612 (Supreme Court, 1964)
In Re Genentech, Inc.
566 F.3d 1338 (Federal Circuit, 2009)
Job Haines Home for the Aged v. Young
936 F. Supp. 223 (D. New Jersey, 1996)
Park Inn International, L.L.C. v. Mody Enterprises, Inc.
105 F. Supp. 2d 370 (D. New Jersey, 2000)
Weber v. Basic Comfort Inc.
155 F. Supp. 2d 283 (E.D. Pennsylvania, 2001)
Saint-Gobain Calmar, Inc. v. National Products Corp.
230 F. Supp. 2d 655 (E.D. Pennsylvania, 2002)
United States v. Klearman
82 F. Supp. 2d 372 (E.D. Pennsylvania, 1999)
Synthes, Inc. v. Knapp
978 F. Supp. 2d 450 (E.D. Pennsylvania, 2013)
Plum Tree, Inc. v. Stockment
488 F.2d 754 (Third Circuit, 1973)

Cite This Page — Counsel Stack

Bluebook (online)
United States v. WARREN, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-warren-paed-2022.